GRF-P Grifols SA

8.270USD7.540 EUR · BME-3.21%Mkt Cap: —P/E: —

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit3.14B USD
Net Income (TTM)440.91M USD
Revenue/Share—
Last Price8.270 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryES
SectorHealthcare
IndustryDrug Manufacturers - General
ISINES0171996095
Valuation
P/E (Trailing)—
P/E (Forward)6.47
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
6.73467% of range9.027
52W High9.027 USD
52W Low6.734 USD
Profitability
Gross Margin38.00%
Oper. Margin—
EBITDA Margin—
Profit Margin5.34%
ROE7.63%
ROA2.04%
ROIC6.22%
ROCE7.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF1.15B USD
CapEx (TTM)463.95M USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity1.81
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate—
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)23.38 USD
Upside (mean)+182.8%
Target Range19.74 USD – 27.97 USD
19.74+182.8% to mean27.97
# Analysts8
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 507.642 (+8.2%)
SMA 2007.607 (+8.7%)
Beta—
S&P 52W Chg—
Avg Vol (30d)110.11K
Avg Vol (10d)126.27K
Technical Indicators
RSI (14)53.9
MACD0.2415
MACD Signal0.2667
MACD Hist.-0.0252
BB Upper8.995 USD
BB Middle8.305 USD
BB Lower7.615 USD
BB Width16.61%
ATR (14)0.2158 USD
Vol Ratio (20d)0.61x

About Grifols (BME: GRF-P)

›

Grifols (BME: GRF-P) is listed on the Bolsa de Madrid, where its shares trade in EUR. It belongs to the Drug Manufacturers - General industry, part of the Healthcare sector.

The shares were at 7.540 EUR on 19 November 2026, up 2.7% over 52 weeks. Its 52-week range is 6.140 EUR to 8.230 EUR: the price is 8.4% below the high and 22.8% above the low.

Grifols reports return on equity of 7.6%.

Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 8 analysts cover the stock, with an average rating of Buy; their mean price target of 21.32 EUR is 182.8% above the current price.